News

2021/04/20

Medivir to participate at the Kempen Life Sciences Conference

Read more
2021/04/19

Medivir has determined the starting dose for the next part of the phase Ib study with MIV-818

Read more
2021/04/16

Medivir appoints Magnus Christensen as interim CEO

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.